GCN2 inhibition sensitizes arginine-deprived hepatocellular carcinoma cells to senolytic treatment
Rindert Missiaen, Nicole Anderson, Laura C. Kim, Bailey Nance, Michelle Burrows, Nicolas Skuli, Madeleine Carens, Romain Riscal, An Steensels, Fuming Li, M. Celeste Simon
Topics & Concepts
ArginineCancer researchHCCSBiologyCell cycleHepatocellular carcinomaCell cycle checkpointApoptosisAmino acidBiochemistryAmino Acid Enzymes and MetabolismCancer, Hypoxia, and MetabolismCancer Research and Treatments